February 28, 2017 6:25 AM ET

Biotechnology

Company Overview of Capricor Therapeutics, Inc.

Key Executives for Capricor Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Linda Marban Ph.D.18 RelationshipsCo-Founder, Chief Executive Officer, President and Director53
Frank Litvack M.D., FACC73 RelationshipsExecutive Chairman and Chairman of Compensation Committee60
Eduardo Marban M.D., Ph.D.37 RelationshipsCo-Founder and Chairman of Scientific Advisor Board--
Leland J. Gershell M.D., Ph.D.No RelationshipsChief Financial Officer and Principal Financial Officer44
Deborah D. Ascheim M.D.No RelationshipsChief Medical Officer51
View More Key Executives

Capricor Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Frank Litvack M.D., FACC 73 RelationshipsCapricor Therapeutics, Inc.60
Linda Marban Ph.D. 18 RelationshipsCapricor Therapeutics, Inc.53
Eduardo Marban M.D., Ph.D. 37 RelationshipsCapricor Therapeutics, Inc.--
Earl M. Collier Jr., J.D., Esq. 90 RelationshipsCapricor Therapeutics, Inc.69
George W. Dunbar Jr. 77 RelationshipsIsto Biologics69
View All Board Members

Capricor Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee M.D., FACCFrank Litvack73 Relationships4 Executives
Nominating Committee Jr., J.D., Esq.Earl M. Collier90 Relationships2 Executives
Corporate Governance Committee Jr., J.D., Esq.Earl M. Collier90 Relationships2 Executives
Advisory Board M.D., Ph.D.Eduardo Marban37 Relationships12 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$232.9K
232.9K
354.2K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$232.9K
232.9K
17.6M
Compensation as of Fiscal Year 2015
Capricor Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

CTI BioPharma Corp. Announces Executive Changes, with Effect from March 20, 2017
February 27, 2017 6:30 AM ET
Rigel Pharmaceuticals, Inc. Announces Board Changes
February 24, 2017 10:24 PM ET
Sangamo Therapeutics, Inc. Announces Termination of Dale Ando as Chief Medical Officer
February 24, 2017 10:10 PM ET
Ian Smith Notifies Ophthotech Corporation Request Not to Be Nominates for Re-Election to the Board of Directors
February 24, 2017 9:14 PM ET
Santhera Pharmaceuticals Opens of U.S. Office in Burlington, MA; Appoints Todd Bazemore to Lead U.S. Operations in Burlington, MA
February 24, 2017 1:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Capricor Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.